ACQUISITION ANNOUNCEMENT – January 26, 2021
Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) closes
Acquisition of Purnovate Therapies
Acquisition Expands Adial’s Portfolio with Drug
Candidates for Treatment of Pain and Addiction

An Adial Company

PURNOVATE
Read the Announcement